Human Subcutaneous Adipose Tissue Sampling Using a Mini-Liposuction Technique
September 27th, 2021
3.6K views
The manuscript and associated video demonstrate a percutaneous biopsy technique to obtain samples of subcutaneous adipose tissue from areas surrounding the umbilicus. This method is a low-risk and efficient way to investigate a range of parameters (e.g., gene or protein expression, enzyme activity, lipid content) within adipose tissue.
Overview
This manuscript presents a percutaneous biopsy technique for obtaining subcutaneous adipose tissue samples from around the umbilicus. It is a low-risk, efficient method for studying various parameters within adipose tissue.
Key Study Components
Area of Science
- Biopsy techniques
- Adipose tissue physiology
- Metabolic function
Background
- The technique is suitable for studies with before-and-after designs.
- It allows characterization of specific populations without requiring excessive tissue.
- It is relatively cost-effective and minimally painful.
- Multiple biopsies can be performed on the same participant in one day.
Purpose of Study
- To enhance understanding of adipose tissue physiology.
- To investigate the relationship between adipose tissue and metabolic diseases.
- To provide a reliable method for tissue sampling in research.
Methods Used
- Preparation of a private, clean room for the procedure.
- Use of 70% ethanol for surface disinfection.
- Participant positioned supine on a comfortable bed.
- Execution of the biopsy technique to collect tissue samples.
Main Results
- Demonstrated effectiveness of the biopsy technique.
- Highlighted low-risk nature and efficiency of the method.
- Showed potential for multiple samples from the same participant.
- Contributed to understanding of adipose tissue's role in metabolic function.
Conclusions
- The percutaneous biopsy technique is a valuable tool for researchers.
- It supports investigations into adipose tissue and metabolic health.
- Future studies can leverage this method for deeper insights.
Frequently Asked Questions
What is the main advantage of this biopsy technique?
It is low-risk, cost-effective, and allows for multiple biopsies on the same day.
How should the room be prepared for the procedure?
The room should be private, with clean, wipeable surfaces and a comfortable bed.
Can this technique be used for different studies?
Yes, it is suitable for studies with before-and-after designs and specific population characterizations.
Is the procedure painful for participants?
The technique is designed to be almost pain-free.
What types of analyses can be performed on the samples?
Samples can be analyzed for gene expression, protein levels, enzyme activity, and lipid content.
How does this technique contribute to understanding metabolic function?
It aids in exploring the physiological roles of adipose tissue in health and disease.
Executive Industry Relevance
This minimally invasive adipose tissue sampling technique enables repeated tissue collection from human participants, supporting longitudinal metabolic studies and target validation in obesity and diabetes research. By providing access to disease-relevant human tissue without surgical intervention, it reduces reliance on animal models and improves translational confidence in preclinical target de-risking. The method supports assay development and biomarker discovery pipelines by supplying consistent, quantifiable samples for mechanistic analysis.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables direct interrogation of human adipose tissue biology for target hypothesis testing and pathway clarification.
- Operational Value: Supports repeated sampling within 24 hours, facilitating before-after intervention studies to assess target engagement and pharmacological response.
- Predictive Value: Provides human-relevant data to de-risk targets early in discovery by linking molecular changes to metabolic function.
Screening & Assay Development
- Scientific Value: Delivers quantifiable tissue yields (~200 mg per biopsy) suitable for biochemical, enzymatic, and omics analyses.
- Operational Value: Standardized, reproducible procedure with minimal participant downtime enables high-throughput sample collection for assay validation.
- Assay Readiness: Generates consistent samples for screening compound effects on lipid metabolism, inflammatory signaling, and adipokine secretion.
Translational & Preclinical Research
- Translational Continuity: Bridges in vitro findings to human physiology by providing disease-relevant tissue from target populations.
- Biomarker Alignment: Enables measurement of translational biomarkers (e.g., lipid content, enzyme activity) directly from sampled tissue to support go/no-go decisions.
- Risk-Adjusted Advancement: Supports preclinical-to-clinical transition by validating target modulation in human tissue prior to costly clinical trials.
Pipeline & Workflow Integration
The technique integrates into early discovery workflows by supplying human tissue for target validation, progressing to assay development for compound screening, and enabling translational validation in preclinical models through biomarker continuity.
- Discovery Biology: Supports hypothesis-driven interrogation of adipose tissue pathways and target validation in metabolic disease models.
- Screening: Provides standardized, reproducible tissue samples for assessing compound effects on adipocyte function and metabolic signaling.
- Analytics: Enables quantitative readouts such as lipid accumulation, gene expression, and protein activity to compare experimental conditions.
- Translational Research: Connects in vitro findings to human tissue responses via measurable biomarkers like adipokine release and metabolic flux.
- Enterprise Reuse: Establishes a reusable tissue acquisition capability across metabolic, inflammatory, and endocrine discovery programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by generating human tissue data that reduces mechanistic ambiguity in target validation.
- Operational Value: Ensures standardization, reproducibility, and scalability through aseptic technique and minimal training requirements.
- Strategic Value: Improves go/no-go decision-making by providing early human tissue evidence, reducing late-stage biological risk and capital inefficiency.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on human adipose tissue response data.
Implementation Considerations
- Requires training in aseptic technique and local anesthetic administration by qualified personnel.
- Needs access to sterile surgical supplies, liposuction needles, syringes, and biosafety waste disposal.
- Demands cross-team standardization between research, clinical, and laboratory staff for consistent sample handling.
- Requires adaptation considerations when sampling from different adipose depots or participant populations (e.g., obese, diabetic).
- Limited by participant comfort and tissue yield variability; not suitable for studies requiring large tissue masses (>1g per session).
Biopharma FAQs
Why is null hypothesis testing important for target validation in adipose tissue studies?
Null hypothesis testing ensures observed changes in tissue biomarkers (e.g., enzyme activity, lipid content) are statistically significant and not due to random variation, supporting confident target engagement conclusions.
How does isolating independent variables (e.g., drug dose, time) improve discovery pipeline efficiency?
By controlling variables such as compound concentration and exposure time, researchers can attribute changes in adipose tissue samples directly to the intervention, improving data interpretability and reducing false positives in screening.
What quantitative dependent variable measurements enable target validation in this biopsy method?
Measurements such as lipid accumulation, adipokine secretion, and gene expression levels provide quantifiable endpoints to assess target modulation and biological response in human adipose tissue.
Why are replication requirements critical for cross-functional collaboration in adipose tissue research?
Replication across biopsies and participants ensures data reliability, enabling consistent interpretation between discovery biology, assay development, and preclinical teams for aligned decision-making.
What statistical analysis capabilities are required before implementing this biopsy technique in a discovery workflow?
Researchers must be able to perform t-tests, ANOVA, or regression analysis on biomarker data from sampled tissue to determine significant differences between pre- and post-intervention conditions.
Chapters in this video
0:04
Introduction
0:49
Laboratory Room Preparation
1:35
Participant Preparation
2:33
Biopsy Procedure–Instructions for the Biopsy Taker
6:39
Post-Biopsy Procedure
7:42
Results: Mini–Liposuction Technique for Subcutaneous Adipose Tissue Sampling from the Abdominal Area
8:14
Conclusion
